Further Patent Applications submitted by Luoda Pharma
The Company is pleased to announce that it submitted the following patents: Provisional Application number 2015905079 – Methods and Compositions for Treating Gastric Ulcers with Esomeprazole (filed 8 December 2015) Provisional Application number 2015905078 – [...]
Luoda signs second major partnership with Big Pharma company
Luoda is pleased to announce that on 14 December, it signed a partnership with a major animal health company for the research and development of a patented treatment for bovine mastitis. The commercial terms of [...]
New Luoda-supported research article on Bovine Mastitis published
Research and Development programmes funded by Luoda have assisted the authors of a new journal article on treatments for Bovine Mastitis: Khazandi, M., P. Eats, D. Trott, E. Ebrahimie, J. Perry, E. Hickey, S. Page, [...]
Pimobendan liquid formulation acceptability study completed
A study has recently been completed that compared the ease of administration or voluntary acceptance by dogs of the Luoda liquid formulation of pimobendan compared with the currently marketed commercial alternative, which are chewable tablets. 10 dogs [...]
Luoda Successfully Completes $1M Capital Raise
Luoda is pleased to announce that it has raised approximately $1,000,000 in additional capital from over a dozen external investors in Australia and from abroad. The directors believe this gives Luoda enough resources to ambitiously [...]
Luoda signs Distribution & Development Agreement with Global Top 10 Pharmaceutical Company
Luoda has today signed a major Distribution & Development Agreement with a Global Top 10 Pharmaceutical Company and a leader in animal health. The Agreement sets out a partnership framework for commercialising one of Luoda’s [...]